Join Our Newsletter
Join our subscribers list to get the latest news, updates and special offers directly in your inbox
A groundbreaking Nature study shows that COVID-19 mRNA vaccines may enhance cancer immunotherapy by unleashing powerful immune responses, turning resistant tumors into treatment-ready targets — a discovery that could transform oncology forever.
Scientists at the Francis Crick Institute and Vividion Therapeutics have developed a new compound that blocks cancer’s growth signal without damaging healthy cells. The discovery, published in Science, marks a major advance in safer, targeted cancer treatments now entering human clinical trials.